388 related articles for article (PubMed ID: 30658382)
1. Semaphorin Signaling in Cancer-Associated Inflammation.
Franzolin G; Tamagnone L
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658382
[TBL] [Abstract][Full Text] [Related]
2. Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer.
Mastrantonio R; You H; Tamagnone L
Theranostics; 2021; 11(7):3262-3277. PubMed ID: 33537086
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin signals tweaking the tumor microenvironment.
Muratori C; Tamagnone L
Adv Cancer Res; 2012; 114():59-85. PubMed ID: 22588056
[TBL] [Abstract][Full Text] [Related]
4. Relation of immune semaphorin/plexin signaling to carcinogenesis.
Műzes G; Sipos F
Eur J Cancer Prev; 2014 Sep; 23(5):469-76. PubMed ID: 24922268
[TBL] [Abstract][Full Text] [Related]
5. The semaphorins and their receptors as modulators of tumor progression.
Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
Drug Resist Updat; 2016 Nov; 29():1-12. PubMed ID: 27912840
[TBL] [Abstract][Full Text] [Related]
6. Semaphorins as Regulators of Phenotypic Plasticity and Functional Reprogramming of Cancer Cells.
Gurrapu S; Tamagnone L
Trends Mol Med; 2019 Apr; 25(4):303-314. PubMed ID: 30824197
[TBL] [Abstract][Full Text] [Related]
7. The potential of class 3 semaphorins as both targets and therapeutics in cancer.
Mishra R; Kumar D; Tomar D; Chakraborty G; Kumar S; Kundu GC
Expert Opin Ther Targets; 2015 Mar; 19(3):427-42. PubMed ID: 25434284
[TBL] [Abstract][Full Text] [Related]
8. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.
Kigel B; Varshavsky A; Kessler O; Neufeld G
PLoS One; 2008 Sep; 3(9):e3287. PubMed ID: 18818766
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin7A: branching beyond axonal guidance and into immunity.
Garcia-Areas R; Libreros S; Iragavarapu-Charyulu V
Immunol Res; 2013 Dec; 57(1-3):81-5. PubMed ID: 24222277
[TBL] [Abstract][Full Text] [Related]
10. Neuropilins in the Context of Tumor Vasculature.
Niland S; Eble JA
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717262
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment--two sides of a coin.
Capparuccia L; Tamagnone L
J Cell Sci; 2009 Jun; 122(Pt 11):1723-36. PubMed ID: 19461072
[TBL] [Abstract][Full Text] [Related]
12. A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer.
Zhang X; Klamer B; Li J; Fernandez S; Li L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):45. PubMed ID: 32241267
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
14. The involvement of semaphorin 7A in tumorigenic and immunoinflammatory regulation.
Song Y; Wang L; Zhang L; Huang D
J Cell Physiol; 2021 Sep; 236(9):6235-6248. PubMed ID: 33611799
[TBL] [Abstract][Full Text] [Related]
15. Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression.
Toledano S; Nir-Zvi I; Engelman R; Kessler O; Neufeld G
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696103
[No Abstract] [Full Text] [Related]
16. Semaphorin signaling in vascular and tumor biology.
Neufeld G; Lange T; Varshavsky A; Kessler O
Adv Exp Med Biol; 2007; 600():118-31. PubMed ID: 17607951
[TBL] [Abstract][Full Text] [Related]
17. Experimental Approaches for Studying Semaphorin Signals in Tumor Growth and Metastasis in Mouse Models.
Moiso E; Accardo M; Tamagnone L
Methods Mol Biol; 2017; 1493():467-484. PubMed ID: 27787871
[TBL] [Abstract][Full Text] [Related]
18. Semaphorins in health and disease.
Fard D; Tamagnone L
Cytokine Growth Factor Rev; 2021 Feb; 57():55-63. PubMed ID: 32900601
[TBL] [Abstract][Full Text] [Related]
19. The role of the semaphorins in cancer.
Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
Cell Adh Migr; 2016 Nov; 10(6):652-674. PubMed ID: 27533782
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin signaling in bone.
Verlinden L; Vanderschueren D; Verstuyf A
Mol Cell Endocrinol; 2016 Sep; 432():66-74. PubMed ID: 26365296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
